Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
暂无分享,去创建一个
G. Rubin | E. Souied | C. Hoyng | A. Tufail | M. Varano | M. Parravano | H. Dunbar | U. Luhmann | M. Wintergerst | J. Terheyden | G. Montesano | D. Crabb | R. Finger | G. Staurenghi | S. Schmitz-Valckenberg | M. Schmid | J. Cunha-Vaz | F. Bandello | L. Altay | Z. Mulyukov | C. Boon | S. Penas | E. Fletcher | A. Binns | M. Sassmannshausen | R. Atia | J. Siedlecki | L. Kühlewein | M. Pfau | S. Thiele | S. Leal | C. Sánchez | L. Wintergerst | H. Agostini | M. Gutfleisch | T. Peto | Â. Carneiro | A. Lüning | L. Vieweg | T. Butt | C. Dahlke | M. Berger | C. Bouchet | C. Behning | M. Böttger | Stephen H Poor | D. Taylor | N. Zakaria | C. Carapezzi | R. Coimbra | F. Holz | C. Martinho | A. Skelly | L. Stöhr | R. Hogg | Y. Lechanteur | I. Marques | M. Cozzi | B. Parodi | L. de Sisternes | M. Belmouhand | H. L. R. F. P. G. C. M. M. A. C. J. F. M. C. J. E. T. Agostini Altay Atia Bandello Basile Behning Be | J. Carlton | C. Francisco | M. Larsen | S. Priglinger | O. Sander | H. Schrinner-Fenske | R. Silva | A. Wolf | J. Sahel | Davide Garzone | Olivier Morelle | M. Paques | J. Brazier | A. Kilani | T. Peters | J. Krätzschmar | P. Basile | A. Charil | D. Rowen
[1] U. Luhmann,et al. Intersession Repeatability of Structural Biomarkers in Early and Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report , 2022, Translational vision science & technology.
[2] Sina Farsiu,et al. COMPARISON OF SINGLE DRUSEN SIZE ON COLOR FUNDUS PHOTOGRAPHY AND SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2021, Retina.
[3] S. Wolf,et al. Comparison of Drusen Volume Assessed by Two Different OCT Devices , 2020, Journal of clinical medicine.
[4] C. Wojek,et al. Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR , 2020, Trials.
[5] Thomas Schultz,et al. Replication and Refinement of an Algorithm for Automated Drusen Segmentation on Optical Coherence Tomography , 2020, Scientific Reports.
[6] S. Sadda,et al. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study. , 2019, Ophthalmology.
[7] G. Rubin,et al. MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration , 2018, Ophthalmologica.
[8] F. Holz,et al. Longitudinal Analysis of Drusen Volume in Intermediate Age-Related Macular Degeneration Using Two Spectral-Domain Optical Coherence Tomography Scan Patterns , 2018, Ophthalmologica.
[9] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[10] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[11] M. V. Cicinelli,et al. Spotlight on reticular pseudodrusen , 2017, Clinical ophthalmology.
[12] Thomas Schultz,et al. CNNs Enable Accurate and Fast Segmentation of Drusen in Optical Coherence Tomography , 2017, DLMIA/ML-CDS@MICCAI.
[13] Thomas Schultz,et al. Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review , 2017, Translational vision science & technology.
[14] Terry K Koo,et al. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.
[15] Michael Pircher,et al. Drusen volume development over time and its relevance to the course of age-related macular degeneration , 2016, British Journal of Ophthalmology.
[16] P. Rosenfeld,et al. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye. , 2016, Investigative ophthalmology & visual science.
[17] Birgit Sander,et al. Do different spectral domain OCT hardwares measure the same? Comparison of retinal thickness using third-party software , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.
[18] Gabriëlle H S Buitendijk,et al. Harmonizing the Classification of Age-related Macular Degeneration in the Three-Continent AMD Consortium , 2014, Ophthalmic epidemiology.
[19] R. Klein,et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.
[20] Qiang Chen,et al. Automated drusen segmentation and quantification in SD-OCT images , 2013, Medical Image Anal..
[21] B. Lujan,et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. , 2011, Ophthalmology.
[22] William J Feuer,et al. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. , 2011, Ophthalmology.
[23] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[24] Joan W. Miller,et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. , 2010, American journal of ophthalmology.
[25] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[26] Sina Farsiu,et al. Lateral and axial measurement differences between spectral-domain optical coherence tomography systems , 2014, Journal of biomedical optics.
[27] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.